HCAT in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with HCAT today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Health Catalyst serves mainly healthcare providers in the United States, including hospitals, health systems and physician practices. Its Ignite cloud platform brings together data from clinical, financial and operational systems so clients can analyze care, costs and how their organizations run. Its applications help clients use those findings to pursue improvements. The company also supplies specialists to implement the software, support clients’ analytics teams or take over functions such as analytics and extracting information from medical records.
Technology subscriptions provide most revenue, with professional services supplying the rest. Clients can buy the full technology suite or selected components. Most revenue is recurring, so retaining clients and selling them additional technology and services are central to the business. Several large clients contribute a meaningful share of revenue, though no single client dominates. The company is moving clients from its older DOS platform to Ignite, a transition that has contributed to smaller contracts and lost clients.
The service depends on reliable access to clients’ data through other vendors’ systems; those vendors can restrict access or charge more. Health Catalyst must also obtain appropriate contractual permissions and comply with health-data privacy rules, including HIPAA. These requirements limit how it can combine patient data and use or share de-identified information.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Health Catalyst’s results hinge on healthcare providers’ analytics budgets and platform adoption; Epic Systems is an important competing electronic health record vendor missing from this list.
Microsoft both competes for the analytics spending that funds Health Catalyst and supplies the Azure computing infrastructure used to deliver its software to healthcare providers. Watch Health Catalyst’s move to Azure: migration and higher hosting costs are weighing on its technology gross margin in the near term.
Oracle’s Oracle Health offerings, built around electronic health records, compete with Health Catalyst’s data platform and analytics for healthcare providers’ technology budgets. Watch whether providers choose Oracle Health through existing relationships and easier integration, which can put pressure on Health Catalyst’s prices and sales.
CareCloud competes with Health Catalyst for providers’ spending on analytics, healthcare IT consulting and outsourced services to improve finances and operations. CareCloud also handles medical billing and claims; its analytics, consulting and managed-services business is the closer comparison with Health Catalyst’s services.
HealthStream and Health Catalyst both depend on healthcare organizations’ spending on software and operational improvement, but HealthStream sells staff training, credentialing and scheduling subscriptions rather than data analytics. Its workforce-software subscriptions offer a separate view of those organizations’ willingness to spend.
Consensus Cloud Solutions and Health Catalyst both benefit from providers investing in usable, connected data: Consensus sells tools to exchange health information and extract data from documents, while Health Catalyst combines provider data for analytics. Watch Consensus’s healthcare-focused business for a view of demand for information exchange, rather than treating its broader fax subscriptions as an analytics comparison.
Fed Interest Rate Decision
Health Catalyst’s Fed interest-rate decision matters because it can shift SOFR, the benchmark rate on its $160.8 million floating-rate term loan, changing the interest the company pays.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher-than-expected rates may lift SOFR and the interest Health Catalyst pays on its term loan, leaving less cash after debt costs for its healthcare data platform and services business.
If it comes in below expectations
Lower-than-expected rates may ease SOFR-linked interest costs, leaving Health Catalyst more cash after debt payments to fund its healthcare data platform and services business.
Consensus Cloud Solutions, Inc. earningsCCSI
Consensus Cloud Solutions’ report offers a read on whether healthcare organizations still want the information exchange and data extraction that help create the connected data Health Catalyst’s analytics rely on.
Focus on Consensus Cloud Solutions’ healthcare business, not its broader fax subscriptions. Strength there would show that organizations are still paying to exchange information and extract data, supporting demand for the connected data Health Catalyst relies on. Weakness would signal softness in this adjacent data path, but would not by itself prove that demand for Health Catalyst’s analytics is falling.
Health Catalyst, Inc earningsThis company
Health Catalyst’s report will show whether platform subscription revenue can keep growing, professional services can stabilize, and migration and hosting costs are squeezing technology gross margin.
Read technology revenue alongside technology gross margin, then check whether professional-services revenue has stopped falling. Rising technology revenue with a steady margin and stabilizing services would show the platform is expanding without costs swallowing the gain. If technology revenue rises but its margin falls, migration or hosting costs may be consuming the growth. If both technology and services weaken, renewals, expansion sales, or client spending remain in question.
Oracle Corp earningsORCL
Oracle’s report will show whether healthcare providers are choosing Oracle Health through existing systems and integration relationships as it competes with Health Catalyst for technology budgets.
Look for Oracle’s discussion of Oracle Health and signs of provider adoption. Stronger traction would show that existing relationships and easier integration help Oracle win healthcare technology budgets, making it harder for Health Catalyst to win platform clients or hold pricing. Weaker traction would mean less evidence of that competitive pressure, not proof that Health Catalyst is winning customers.